A new study suggests the connection between Attention-Deficit/Hyperactivity Disorder (ADHD) and the body’s primary stress ...

Attention deficit hyperactivity disorder (ADHD) is the most common disability diagnosis in children globally. It's estimated ...

Pfizer and Tris Pharma have agreed to pay $41.5m to settle allegations by the Texas Attorney General Ken Paxton ...

Groundbreaking research has uncovered a set of just three gene variants that can increase the likelihood of attention-deficit ...

Pfizer and supplier Tris Pharma reached a $41.5 million settlement with Texas to resolve a lawsuit claiming they defrauded ...

Pfizer Inc. and Tris Pharma Inc. will pay the state of Texas $41.5 million to settle claims that it allegedly provided ...

Powerful psychotropic drugs are often the next step, even though their combined effects in young children haven’t been ...

Pfizer and manufacturer Tris Pharma have agreed to hand over $41.5 million to lay to rest a 2023 lawsuit accusing the ...

Attention-deficit/hyperactivity disorder (ADHD) symptoms are influenced by socioeconomic factors in regions affected by ...

A strengths-based look at how autism and ADHD coexist (AuDHD) reveals five capacities that deepen perception, creativity, ...

Co-occurring ADHD and substance use create unique challenges. The latest research shows what effective treatment really ...

In two newly published studies, researchers at the Department of Ethology, Eötvös Loránd University (Hungary) investigated ...